BIOSU — BioPlus Acquisition Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsAdventurousSmall Cap
- $271.27m
- $276.52m
Annual cashflow statement for BioPlus Acquisition, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | — | 12 M | 12 M |
| Source: | 10-K | 10-K | |
| Standards: | — | USG | USG |
| Status: | fx Preliminary | Final | Final |
| Net Income/Starting Line | — | -0.14 | 2 |
| Non-Cash Items | — | -0.009 | -3.17 |
| Other Non-Cash Items | |||
| Changes in Working Capital | — | -0.625 | 0.48 |
| Change in Prepaid Expenses | |||
| Change in Accrued Expenses | |||
| Cash from Operating Activities | — | -0.774 | -0.691 |
| Other Investing Cash Flow Items | — | -235 | 0 |
| Other Investing Cash Flow | |||
| Cash from Investing Activities | — | -235 | 0 |
| Financing Cash Flow Items | — | 225 | -0.068 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | — | 236 | 0.196 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | — | 0.636 | -0.495 |